MIND Foundation

The MIND Foundation is a Berlin-based nonprofit founded in 2016 that advances psychedelic therapy through research, education, and policy advocacy across Europe, supporting clinical trials including the EPIsoDE psilocybin study and the planned DiMension Phase III trial with over 700 patients. It runs the MIND Academy for professional psychedelic training and hosts the biannual INSIGHT conference connecting researchers, clinicians, and the public.